Home
Categories
EXPLORE
Society & Culture
True Crime
Education
Comedy
History
Religion & Spirituality
Music
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/21/47/dc/2147dc0d-80ee-e140-3e75-681b754c3dae/mza_17619873882747212796.jpg/600x600bb.jpg
MEGIN Spotlights
MEGIN
54 episodes
3 weeks ago
Based in Helsinki, Finland, MEGIN is a global leader in functional neuroimaging, developing innovative solutions for Neurology, Neurosurgery & Research. We are reshaping the field of functional brain imaging, with the aim of ensuring that every scientific advancement translates into meaningful health outcomes for patients worldwide.
Show more...
Technology
Science
RSS
All content for MEGIN Spotlights is the property of MEGIN and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Based in Helsinki, Finland, MEGIN is a global leader in functional neuroimaging, developing innovative solutions for Neurology, Neurosurgery & Research. We are reshaping the field of functional brain imaging, with the aim of ensuring that every scientific advancement translates into meaningful health outcomes for patients worldwide.
Show more...
Technology
Science
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/21/47/dc/2147dc0d-80ee-e140-3e75-681b754c3dae/mza_17619873882747212796.jpg/600x600bb.jpg
Professor Srikantan Nagarajan from University of California, San Francisco
MEGIN Spotlights
27 minutes 52 seconds
5 months ago
Professor Srikantan Nagarajan from University of California, San Francisco
MEGIN Spotlights
Based in Helsinki, Finland, MEGIN is a global leader in functional neuroimaging, developing innovative solutions for Neurology, Neurosurgery & Research. We are reshaping the field of functional brain imaging, with the aim of ensuring that every scientific advancement translates into meaningful health outcomes for patients worldwide.